DMIIUDrugs Made In America Acquisition II Corp. Unit

NAS · US · Financial Services · Shell Companies

10.20USD0.00%Mkt Cap: —P/E: —4d ago

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…

Industry Peers

Shell Companies

Drugs Made In America Acquisition II Corp. Ordinary Shares

$645.92MUSDP/E 35.0

BCSS

Bain Capital GSS Investment Corp. Class A Ordinary Shares

$600.35MUSD

EVAC

EQV Ventures Acquisition Corp. II

$600.26MUSDP/E 14.7

CXII

Churchill Capital Corp XII Class A Ordinary Shares

$595.50MUSD

CEPF

Cantor Equity Partners IV Inc. Class A Ordinary Shares

$590.93MUSDP/E 27.9

AEXA

American Exceptionalism Acquisition Corp. A

$577.70MUSD

DBCA

D. Boral Acquisition I Corp. Class A Ordinary Shares

$555.37MUSD

VACH

Voyager Acquisition Corp Class A Ordinary Shares

$541.25MUSDP/E 81.5

GCGR

General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares

$514.21MUSD

NWAX

New America Acquisition I Corp. Class A Common Stock

$506.96MUSD

MEVO

M Evo Global Acquisition Corp II Class A Ordinary Shares

$499.00MUSD

KRSP

Rice Acquisition Corporation 3

$487.63MUSD

RFAI

RF Acquisition Corp II Ordinary Shares

$483.94MUSDP/E 483.3

GIW

GigCapital8 Corp. Class A Ordinary Shares

$480.90MUSD

GTEN

Gores Holdings X Inc. Class A ordinary shares

$478.70MUSDP/E 6.9

ANSC

Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares

$476.13MUSDP/E 52.1

CRAN

Crane Harbor Acquisition Corp. II Class A Ordinary Shares

$475.57MUSD

APXT

APEX TECHNOLOGY ACQUISITION CORP

$464.43MUSD

IEAG

Infinite Eagle Acquisition Corp. Class A Ordinary Shares

$444.99MUSD

Key Statistics

Company

Market Cap—

Enterprise Value647.93M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)4.19M $

Revenue/Share—

Last Price10.20 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-36.43

EPS (TTM)—

EPS (Forward)—

52W Range

9.93531% of range10.80

52W High10.80 USD

52W Low9.935 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE0.86%

ROA0.83%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.02M $

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt102.28K $

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio0.53

Quick Ratio0.52

Book Value/Sh-0.2800 USD

Cash/Share0.0050 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float50.26M

Insiders1.07%

Institutions5.46%

Short Interest

Short Ratio2.8d

Shares Short172

Short (prev mo.)181

Technical

SMA 5010.16 (+0.4%)

SMA 20010.08 (+1.2%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)502

Avg Vol (10d)470

Technical Indicators

RSI (14)70.7

MACD0.0117

MACD Signal0.0081

MACD Hist.+0.0037

BB Upper10.21 USD

BB Middle10.17 USD

BB Lower10.14 USD

BB Width0.69%

ATR (14)0.0067 USD

Vol Ratio (20d)0.00x